FTSE 100

UK pharmaceutical group Shire saw shares jump 10% by mid-morning, after it revealed it rejected a £27bn bid approach from a US group.

The FTSE 100 was higher by mid-morning despite this morning's data from the ONS revealing a greater than expected fall in the rate of CPI inflation.

‘Newton is not a one-trick pony’

Seeking out ‘shooting stars and fallen angels’

Neil Woodford is considering opening talks with his former firm Invesco Perpetual about a private multi-billion pound deal to bring across his old stakes in the country's largest stocks, and avoid creating havoc in their share prices.

Henderson's Chris Burvill is buying AstraZeneca, among other firms, in a move to benefit from merger and acquisition speculation.

Active fund managers must rise to the challenge of a rotation into FTSE 100 stocks after years of outperformance, wealth managers have warned.

Mid-cap stocks have suffered a harsh and indiscriminate sell-off in recent weeks, and managers have pointed to liquidity concerns as a possible trigger for the falls.

‘I am more cautious on UK growth than the crowded consensus’

UK election countdown: The start of a volatile year?